Ryanodex 250 MG vials
Ended Awarded Last action
- Contract number
- SPE2D326F0796
- Awardee
-
Eagle Pharmaceuticals, Inc. UEI VRQKPMHD3CK7
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $10,585
Award facts
- Contract value 100% obligated
- $10,585.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Westwood, NJ 07677, USA
Award details come from SAM.gov/FPDS.
About this award
Eagle Pharmaceuticals, Inc. was awarded a delivery order valued at $10,585.32 for the supply of Ryanodex 250 mg vials, a specialized injectable medication used to treat and prevent malignant hyperthermia. The contract was awarded on October 22, 2025, with an ultimate completion date of October 27, 2025, and carries no set-aside designation. Performance will take place at Eagle Pharmaceuticals' manufacturing facility in Westwood, New Jersey. Funding is provided by the Medical Supply Chain division, which supports Defense Department operations. This delivery order is issued under Eagle Pharmaceuticals' larger Federal Supply Schedule contract with the Department of Veterans Affairs Veterans Integrated Service Network 12, a multiple-award vehicle valued at $30.9 million with a completion date of January 31, 2029, that enables both Veterans Affairs and Defense Logistics Agency procurement of essential pharmaceutical products.
Eagle Pharmaceuticals serves as the prime contractor with no identified subcontractors and has established itself as a reliable federal supplier of critical injectable medications since 2016. The company specializes in high-risk pharmaceutical products essential to military medical readiness and veterans' healthcare across Veterans Affairs facilities in the Northeast. This delivery order reflects the company's consistent role as a specialized supplier within the federal medical supply chain, with the firm fixed-price contract type providing cost certainty for this essential pharmaceutical procurement.
Quick answers
Who was awarded contract SPE2D326F0796?
SPE2D326F0796 was awarded to Eagle Pharmaceuticals, Inc. by Medical Supply Chain (Troop Support) on October 22, 2025.
How much is contract SPE2D326F0796 worth?
The government has obligated $10,585 on SPE2D326F0796.
Is contract SPE2D326F0796 an order under another contract?
Yes. SPE2D326F0796 is a delivery order under SPE2D018D0006, an indefinite delivery contract.
Was contract SPE2D326F0796 competed?
The extent of competition for SPE2D326F0796 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award